{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:09:35Z","timestamp":1791864575260,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012477"],"award-info":[{"award-number":["2023A1515012477"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200820"],"award-info":[{"award-number":["82200820"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202201011483"],"award-info":[{"award-number":["202201011483"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Laboratory of Nephrology, Guangdong Province","award":["2020B1212060028"],"award-info":[{"award-number":["2020B1212060028"]}]},{"name":"5010 Clinical Program of Sun Yat-Sen University","award":["2017007"],"award-info":[{"award-number":["2017007"]}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2021YFC2501302"],"award-info":[{"award-number":["2021YFC2501302"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04040-6","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T11:02:17Z","timestamp":1712055737000},"page":"3003-3011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Differences of clinicopathological characteristics and outcomes of IgA nephropathy patients with and without nephrotic syndrome"],"prefix":"10.1007","volume":"56","author":[{"given":"Naya","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6385-5482","authenticated-orcid":false,"given":"Qinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"4040_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00281-021-00888-3","volume":"43","author":"J Floege","year":"2021","unstructured":"Floege J, Rauen T, Tang SCW (2021) Current treatment of IgA nephropathy. Semin Immunopathol 43:717\u2013728","journal-title":"Semin Immunopathol"},{"key":"4040_CR2","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","volume":"368","author":"RJ Wyatt","year":"2013","unstructured":"Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402\u20132414","journal-title":"N Engl J Med"},{"key":"4040_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"78","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut P, Avila-Casado C, Reich HN (2021) IgA nephropathy: core curriculum 2021. Am J Kidney Dis 78:429\u2013441","journal-title":"Am J Kidney Dis"},{"key":"4040_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","volume":"361","author":"A Rajasekaran","year":"2021","unstructured":"Rajasekaran A, Julian BA, Rizk DV (2021) IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci 361:176\u2013194","journal-title":"Am J Med Sci"},{"key":"4040_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1440-1797.2007.00898.x","volume":"13","author":"J Lv","year":"2008","unstructured":"Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H (2008) Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Nephrology (Carlton) 13:242\u2013246","journal-title":"Nephrology (Carlton)"},{"key":"4040_CR6","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1681\/ASN.2017010108","volume":"28","author":"AM Sevillano","year":"2017","unstructured":"Sevillano AM, Gutierrez E, Yuste C, Cavero T, Merida E, Rodriguez P, Garcia A, Morales E, Fernandez C, Martinez MA, Moreno JA, Praga M (2017) Remission of hematuria improves renal survival in IgA nephropathy. J Am Soc Nephrol 28:3089\u20133099","journal-title":"J Am Soc Nephrol"},{"key":"4040_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12882-022-02799-3","volume":"23","author":"H Li","year":"2022","unstructured":"Li H, Wang F, Jia J, Yan T, Liu Y, Lin S (2022) The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study. BMC Nephrol 23:163","journal-title":"BMC Nephrol"},{"key":"4040_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40620-015-0242-9","volume":"29","author":"XW Li","year":"2016","unstructured":"Li XW, Liang SS, Le WB, Cheng SQ, Zeng CH, Wang JQ, Liu ZH (2016) Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease. J Nephrol 29:567\u2013573","journal-title":"J Nephrol"},{"key":"4040_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2215\/CJN.04820511","volume":"7","author":"JK Kim","year":"2012","unstructured":"Kim JK, Kim JH, Lee SC, Kang EW, Chang TI, Moon SJ, Yoon SY, Yoo TH, Kang SW, Choi KH, Han DS, Kie JH, Lim BJ, Jeong HJ, Han SH (2012) Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol 7:427\u2013436","journal-title":"Clin J Am Soc Nephrol"},{"key":"4040_CR10","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1080\/0886022X.2022.2113796","volume":"44","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yang A, Hou Y, Liu L, Lin J, Huang X, Li J, Liu X, Lu F, Lin Q, Yang H, Yue S, Jiang S, Wang L, Zou C (2022) Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role? Ren Fail 44:1443\u20131453","journal-title":"Ren Fail"},{"key":"4040_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10238-019-00580-9","volume":"19","author":"X Han","year":"2019","unstructured":"Han X, Xiao Y, Tang Y, Zheng X, Anwar M, Qin W (2019) Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome. Clin Exp Med 19:479\u2013486","journal-title":"Clin Exp Med"},{"key":"4040_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"DC Cattran","year":"2009","unstructured":"Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D\u2019Agati V, D\u2019Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) Society WGotIINNatRP: the Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534\u2013545","journal-title":"Kidney Int"},{"key":"4040_CR13","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/jcm9072058","volume":"9","author":"JS Suh","year":"2020","unstructured":"Suh JS, Jang KM, Hyun H, Cho MH, Lee JH, Park YS, Oh JH, Kim JH, Yoo KH, Chung WY, Kim SH, Kim K, Lee DY, Lee JW, Cho MH, Park H, Koo JW, Han KH, Yang EM, Lee KH, Shin JI, Cho H, Kim KS, Ha IS, Park YH, Kang HG (2020) Remission of proteinuria may protect against progression to chronic kidney disease in pediatric-onset IgA nephropathy. J Clin Med 9:2058","journal-title":"J Clin Med"},{"key":"4040_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5414\/CN107682","volume":"79","author":"J Qin","year":"2013","unstructured":"Qin J, Yang Q, Tang X, Chen W, Li Z, Mao H, Jiang Z, Huang F, Yu X (2013) Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease. Clin Nephrol 79:37\u201344","journal-title":"Clin Nephrol"},{"key":"4040_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00467-016-3502-6","volume":"32","author":"Y Shima","year":"2017","unstructured":"Shima Y, Nakanishi K, Sato M, Hama T, Mukaiyama H, Togawa H, Tanaka R, Nozu K, Sako M, Iijima K, Suzuki H, Yoshikawa N (2017) IgA nephropathy with presentation of nephrotic syndrome at onset in children. Pediatr Nephrol 32:457\u2013465","journal-title":"Pediatr Nephrol"},{"key":"4040_CR16","first-page":"503","volume":"18","author":"R Coppo","year":"2005","unstructured":"Coppo R, D\u2019Amico G (2005) Factors predicting progression of IgA nephropathies. J Nephrol 18:503\u2013512","journal-title":"J Nephrol"},{"key":"4040_CR17","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.3390\/jcm9082619","volume":"9","author":"WH Cho","year":"2020","unstructured":"Cho WH, Park SH, Choi SK, Jung SW, Jeong KH, Kim YG, Moon JY, Lim SJ, Sung JY, Jhee JH, Chin HJ, Choi BS, Lee SH (2020) Characterization of IgA deposition in the kidney of patients with IgA nephropathy and minimal change. J Clin Med 9:2619","journal-title":"J Clin Med"},{"key":"4040_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.793511","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Lu W, Li H, Liu X, Zhang X, Xie L, Lan P, Yu X, Dai Y, Xie X, Lv J (2021) Immune characteristics of IgA nephropathy with minimal change disease. Front Pharmacol 12:793511","journal-title":"Front Pharmacol"},{"key":"4040_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5414\/CN108727","volume":"85","author":"XW Li","year":"2016","unstructured":"Li XW, Cheng SQ, Liang SS, Le WB, Zeng CH, Wang JQ, Liu ZH (2016) Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease. Clin Nephrol 85:273\u2013281","journal-title":"Clin Nephrol"},{"key":"4040_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.ajkd.2019.02.016","volume":"74","author":"T Chen","year":"2019","unstructured":"Chen T, Li X, Li Y, Xia E, Qin Y, Liang S, Xu F, Liang D, Zeng C, Liu Z (2019) Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am J Kidney Dis 74:300\u2013309","journal-title":"Am J Kidney Dis"},{"key":"4040_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/07853890.2021.1897664","volume":"53","author":"F Yu","year":"2021","unstructured":"Yu F, Zhu X, Yuan S, Chen X, Li Z, Qu Z, Liu H, Sun L, Liu F (2021) Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy. Ann Med 53:587\u2013595","journal-title":"Ann Med"},{"key":"4040_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223218","volume":"14","author":"D Shi","year":"2019","unstructured":"Shi D, Chan H, Yang X, Zhang G, Yang H, Wang M, Li Q (2019) Risk factors associated with IgA vasculitis with nephritis (Henoch-Schonlein purpura nephritis) progressing to unfavorable outcomes: a meta-analysis. PLoS ONE 14:e0223218","journal-title":"PLoS ONE"},{"key":"4040_CR23","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s11255-020-02457-3","volume":"52","author":"F Ma","year":"2020","unstructured":"Ma F, Liu L, Dong R, Yang X, Wei L, Li L, Bai M, Sun S (2020) Renal survival and risk factors in IgA nephropathy with crescents. Int Urol Nephrol 52:1507\u20131516","journal-title":"Int Urol Nephrol"},{"key":"4040_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.ajkd.2019.11.008","volume":"76","author":"GZ Yu","year":"2020","unstructured":"Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H (2020) Persistent hematuria and kidney disease progression in IgA nephropathy: a cohort study. Am J Kidney Dis 76:90\u201399","journal-title":"Am J Kidney Dis"},{"key":"4040_CR25","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.3390\/jcm11226785","volume":"11","author":"M Weng","year":"2022","unstructured":"Weng M, Lin J, Chen Y, Zhang X, Zou Z, Chen Y, Cui J, Fu B, Li G, Chen C, Wan J (2022) Time-averaged hematuria as a prognostic indicator of renal outcome in patients with IgA nephropathy. J Clin Med 11:6785","journal-title":"J Clin Med"},{"key":"4040_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s40620-022-01273-5","volume":"35","author":"Y Ruan","year":"2022","unstructured":"Ruan Y, Hong F, Wu J, Lin M, Wang C, Lian F, Cao F, Yang G, Huang L, Huang Q (2022) Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents. J Nephrol 35:1113\u20131121","journal-title":"J Nephrol"},{"issue":"Suppl 1","key":"4040_CR27","first-page":"76","volume":"10","author":"S Kuster","year":"1990","unstructured":"Kuster S, Mehls O, Seidel C, Ritz E (1990) Blood pressure in minimal change and other types of nephrotic syndrome. Am J Nephrol 10(Suppl 1):76\u201380","journal-title":"Am J Nephrol"},{"key":"4040_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2010.39","volume":"303","author":"BR Hemmelgarn","year":"2010","unstructured":"Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M (2010) Alberta kidney disease N: relation between kidney function, proteinuria, and adverse outcomes. JAMA 303:423\u2013429","journal-title":"JAMA"},{"key":"4040_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ki.1985.222","volume":"28","author":"JC Jennette","year":"1985","unstructured":"Jennette JC, Wall SD, Wilkman AS (1985) Low incidence of IgA nephropathy in blacks. Kidney Int 28:944\u2013950","journal-title":"Kidney Int"},{"key":"4040_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0272-6386(00)70316-7","volume":"35","author":"P Maisonneuve","year":"2000","unstructured":"Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (2000) Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia\/New Zealand: results from an international comparative study. Am J Kidney Dis 35:157\u2013165","journal-title":"Am J Kidney Dis"},{"key":"4040_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ng.1047","volume":"44","author":"XQ Yu","year":"2012","unstructured":"Yu XQ, Li M, Zhang H, Low HQ, Wei X, Wang JQ, Sun LD, Sim KS, Li Y, Foo JN, Wang W, Li ZJ, Yin XY, Tang XQ, Fan L, Chen J, Li RS, Wan JX, Liu ZS, Lou TQ, Zhu L, Huang XJ, Zhang XJ, Liu ZH, Liu JJ (2012) A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet 44:178\u2013182","journal-title":"Nat Genet"},{"key":"4040_CR32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/81677","volume":"26","author":"AG Gharavi","year":"2000","unstructured":"Gharavi AG, Yan Y, Scolari F, Schena FP, Frasca GM, Ghiggeri GM, Cooper K, Amoroso A, Viola BF, Battini G, Caridi G, Canova C, Farhi A, Subramanian V, Nelson-Williams C, Woodford S, Julian BA, Wyatt RJ, Lifton RP (2000) IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26:354\u2013357","journal-title":"Nat Genet"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04040-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04040-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04040-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:32:32Z","timestamp":1723563152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04040-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04040-6","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"16 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no actual or potential conflicts of financial or non-financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It was not possible to involve patients or the public in the design, or conduct, or reporting, or dissemination plans of our research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}}]}}